查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1629906

全球药品封口机市场 - 2025-2033

Global Pharmaceutical Sealing Machines Market - 2025-2033
出版日期: | 出版商: DataM Intelligence | 英文 179 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2024年，全球药品封口机市场规模达14亿美元，预计2033年将达24亿美元，2025-2033年预测期间复合年增长率为6.3%。

药品封口机是专门设计用于安全密封各种类型的药品包装以确保产品的完整性、安全性和无菌性的专用设备。这些机器在药品製造过程中至关重要，因为它们可以保护药品和其他保健产品免受污染、篡改以及水分、空气和光线等环境因素的影响。总体而言，药品封口机对于确保药品的安全性、有效性和品质至关重要，特别是在严格的监管要求和製药业对更高品质包装解决方案的需求不断增长的背景下。

由于对产品安全、遵守严格法规的需求不断增长以及製药业高产量的扩张，对药品封口机的需求正在稳步增长。例如，封盖机每小时可生产多达 36,000 至 12,000 个小瓶。生物製剂和生物相似药的成长增加了对能够处理敏感包装材料并确保气密密封的密封机的需求。

市场动态：

驱动程式和限制

药品製造业的成长

药品製造的成长极大地推动了药品封口机市场的发展，预计将在预测期内推动该市场的发展。这一趋势主要由多种因素推动，包括对药品需求的增加、生产设施的扩张以及严格监管合规的需要。

糖尿病、心血管疾病和癌症等慢性疾病在全球范围内的上升正在推动医药产品的生产，这反过来又推动了对有效封口机的需求。例如，根据世界卫生组织 (WHO) 的数据，2022 年，慢性病占全球死亡人数的 74%，凸显了对药品的需求不断增长。

生物製剂和生物相似药的成长通常需要专门的包装和密封技术来保持功效并防止污染，这导致对能够处理复杂包装要求的密封机的需求增加。例如，根据美国药物研究和製造商协会的数据，截至2022年底，美国已有40种生物相似药获得批准，市场上有27种生物相似药。

采用下一代密封机可以带来许多优势，特别是在提高无菌性和使用者友善性方面。这减少了停机时间并确保整个生产线的品质一致。例如，2023 年 10 月，领先的医疗保健包装解决方案提供商 TekniPlex Healthcare 在西班牙巴塞隆纳举行的 CPhI 贸易展上展示了其 Pentafill A25 灌装和封口机，展现了对推进药品包装技术的承诺。 Pentafill A25 是 TekniPlex Healthcare 开发的新一代填充封口机。它具有多种优点，主要集中在增强无菌性和用户友好性。

材料相容性问题

材料相容性问题是药品封口机市场面临的重大挑战，因为它们直接影响这些机器的效率、可靠性和采用。由于製药公司采用环保且可生物降解的包装材料，传统的封口机往往难以有效处理这些材料。

例如，针对塑胶和铝进行优化的传统密封机在与可生物降解塑胶或纸基材料一起使用时可能无法提供所需的密封强度或一致性，从而导致生产效率低下并增加浪费。这种转变增加了改造或更换机器的需求，从而增加了营运成本并延迟了采用。

先进材料，例如用于敏感药物的多层薄膜，可能会对实现均匀的热分布和密封强度带来挑战。例如，专为单层材料设计的密封机在与多层薄膜一起使用时可能会导致过热或密封不足，从而导致包装缺陷和产品召回。这会降低生产力并增加浪费，从而增加製造商的成本。

目录

第一章：市场介绍和范围

  • 报告的目标
  • 报告范围和定义
  • 报告范围

第 2 章：高阶主管见解与要点

  • 市场亮点和战略要点
  • 主要趋势和未来预测
  • 按机器类型分類的片段
  • 技术片段
  • 最终使用者的片段
  • 按地区分類的片段

第 3 章：动力学

  • 影响因素
    • 司机
      • 药品製造的成长
      • 不断进步的技术
    • 限制
      • 药品製造的成长
    • 机会
    • 影响分析

第 4 章：策略洞察与产业展望

  • 市场领导者和先驱
    • 新兴先锋和杰出参与者
    • 拥有最大销售品牌的知名领导者
    • 拥有成熟产品的市场领导者
  • 新兴新创企业和关键创新者
  • CXO 观点
  • 最新进展和突破
  • 案例研究/正在进行的研究
  • 监管和报销情况
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 波特五力分析
  • 供应链分析
  • 专利分析
  • SWOT分析
  • 未满足的需求和差距
  • 市场进入和扩张的推荐策略
  • 情境分析：最佳情况、基本情况和最坏情况预测
  • 定价分析和价格动态

第 5 章：药品封口机市场（依机器类型）

  • 西林瓶盖封口机
  • 感应封口机
  • 托盘封口机

第 6 章：依技术分類的药品封口机市场

  • 自动封口机
  • 半自动封口机
  • 手动封口机

第 7 章：药品封口机市场（依最终用户）

  • 製药公司
  • 合约包装组织
  • 研究实验室

第 8 章： 药品封口机市场，按区域市场分析与成长机会

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 中东和非洲

第 9 章：竞争格局与市场定位

  • 竞争概况和主要市场参与者
  • 市占率分析与定位矩阵
  • 策略伙伴关係、併购
  • 产品组合和创新的主要发展
  • 公司基准化分析

第 10 章：公司简介

  • Marchesini Group SpA
    • 公司概况
    • 产品组合和描述
    • 财务概览
    • 主要进展
    • SWOT分析
  • Uhlmann Pac-Systeme GmbH & Co. KG
  • MULTIVAC Group
  • IMA Industria Macchine Automatiche SpA
  • MG2 srl
  • PlexPack
  • Bausch+Strobel SE + Co. KG
  • Audion
  • Syntegon Technology GmbH
  • MGA Technologies

第 11 章：假设与研究方法

  • 资料收集方法
  • 数据三角测量
  • 预测技术
  • 数据验证和确认

第 12 章：附录

简介目录
Product Code: MD8931

The global pharmaceutical sealing machines market reached US$ 1.4 billion in 2024 and is expected to reach US$ 2.4 billion by 2033, growing at a CAGR of 6.3% during the forecast period 2025-2033.

Pharmaceutical sealing machines are specialized equipment designed to securely seal various types of pharmaceutical packaging to ensure the integrity, safety, and sterility of the products. These machines are critical in the pharmaceutical manufacturing process, as they protect medicines and other healthcare products from contamination, tampering, and environmental factors such as moisture, air and light. Overall, pharmaceutical sealing machines are critical in ensuring the safety, efficacy, and quality of pharmaceutical products, especially in the context of stringent regulatory requirements and the increasing demand for higher-quality packaging solutions in the pharmaceutical industry.

The demand for pharmaceutical sealing machines is steadily growing due to the increasing need for product safety, compliance with stringent regulations, and the expansion of the pharmaceutical industry in terms of high production. For instance, the cap-sealing machine can produce up to 36,000 to 12,000 vials in an hour. The growth in biologics and biosimilars has increased the demand for sealing machines capable of handling sensitive packaging materials and ensuring airtight seals.

Market Dynamics: Drivers & Restraints

Growth in pharmaceutical manufacturing

The growth in pharmaceutical manufacturing is significantly driving the pharmaceutical sealing machines market and is expected to drive the market over the forecast period. This trend is primarily driven by several factors, including increased demand for pharmaceutical products, expansion of manufacturing facilities, and the need for stringent regulatory compliance.

The global rise in chronic diseases such as diabetes, cardiovascular conditions, and cancer is boosting the production of pharmaceutical products, which in turn drives the need for effective sealing machines. For instance, according to the World Health Organization (WHO), chronic diseases accounted for 74% of global deaths in 2022, emphasizing the growing need for pharmaceuticals.

The growth of biologics and biosimilars, which often require specialized packaging and sealing technologies to maintain efficacy and prevent contamination, has led to increased demand for sealing machines capable of handling complex packaging requirements. For instance, according to the Pharmaceutical Research and Manufacturers of America, as of the end of 2022, 40 biosimilars have been approved and there are 27 biosimilars on the market in the US.

The adoption of next-generation sealing machines allows advantages, especially by enhancing sterility and user-friendliness. This reduces downtime and ensures consistent quality across manufacturing lines. For instance, in October 2023, TekniPlex Healthcare, a leading provider of healthcare packaging solutions, showcased its Pentafill A25 Filling & Sealing Machine at the CPhI trade show in Barcelona, Spain, demonstrating a commitment to advancing pharmaceutical packaging technology. The Pentafill A25 is a next-generation filling and sealing machine developed by TekniPlex Healthcare. It offers various advantages, primarily focusing on enhancing sterility and user-friendliness.

Material compatibility issues

Material compatibility issues are a significant challenge for the pharmaceutical sealing machines market, as they directly affect the efficiency, reliability and adoption of these machines. As pharmaceutical companies adopt eco-friendly and biodegradable packaging materials, traditional sealing machines often struggle to handle these materials effectively.

For instance, conventional sealing machines optimized for plastic and aluminum may not provide the required seal strength or consistency when used with biodegradable plastics or paper-based materials, leading to production inefficiencies and increased waste. This transition increases the need for retrofitting or replacing machines, which adds to operational costs and delays adoption.

Advanced materials, such as multi-layer films used for sensitive drugs, can cause challenges in achieving uniform heat distribution and sealing strength. For instance, sealing machines designed for single-layer materials may cause overheating or under-sealing when used with multi-layer films, resulting in defective packaging and product recalls. This hampers productivity and increases waste, driving up costs for manufacturers.

Segment Analysis

The global pharmaceutical sealing machines market is segmented based on machine type, technology, end-user and region.

Machine Type:

The induction sealing machines segment is expected to dominate the pharmaceutical sealing machines market share

Induction sealing provides a hermetic (airtight) seal on containers, such as plastic and glass bottles, which prevents contamination from external elements like air, moisture and light. This is critical for preserving the efficacy and shelf life of pharmaceutical products, especially sensitive ones like liquids, creams and powders by providing inspection and process analysis.

For instance, in November 2024, Yoran Imaging introduced a system that provides inspection and process analysis for induction-sealed bottles, jars and vials. Capable of operating at full production speeds, the company's i-PAM induction seal process analytical monitoring system performs non-intrusive through-the-cap thermal imaging inspection of all induction seals and provides process insights to reveal the root causes of current or foreseeable adverse issues.

Induction sealing is widely adopted because it provides tamper-evident seals that are difficult to counterfeit. This meets the regulatory requirements set by bodies such as the FDA and the EU for pharmaceutical packaging. For instance, in the U.S., the Drug Supply Chain Security Act (DSCSA) mandates tamper-evident packaging for prescription drugs, pushing manufacturers to use induction sealing machines to include tamper-evident seals on product containers.

Induction sealing machines are suitable for sealing a wide range of containers and materials, including plastic, glass, and aluminum, which makes them highly adaptable to different pharmaceutical packaging needs. For instance, companies like Uhlmann and other emerging players offer induction sealing machines that can seal PET, HDPE, and glass containers, accommodating different pharmaceutical products such as tablets, syrups, and powders.

Geographical Analysis

North America is expected to hold a significant position in the pharmaceutical sealing machines market share

North America hosts many of the world's leading pharmaceutical companies, including Pfizer, Merck, Johnson & Johnson, and Eli Lilly. These companies have substantial production facilities equipped with state-of-the-art sealing machines to maintain high standards of product quality and compliance. For instance, Pfizer's manufacturing facilities in the United States use advanced sealing technologies to package drugs like biologics and vaccines, which require precise sealing for integrity and stability.

North America is known for having some of the world's most stringent regulatory requirements for pharmaceutical manufacturing. The FDA mandates compliance with cGMP (Current Good Manufacturing Practices), which includes the use of specialized sealing machines to ensure product safety and quality. For instance, pharmaceutical companies in the US use induction sealing machines for tamper-evident seals on products like OTC medications to comply with the DSCSA and EU Falsified Medicines Directive.

North American consumers and regulatory bodies prioritize product security, including anti-counterfeiting measures and serialization. This has led to the widespread use of sealing machines with advanced sealing technologies. For instance, the serialization and anti-tampering features of induction sealing machines are crucial for compliance with U.S. FDA and DSCSA regulations, particularly for prescription drugs.

Asia-Pacific is growing at the fastest pace in the pharmaceutical sealing machines market

The Asia-Pacific region is witnessing a significant expansion in pharmaceutical manufacturing facilities, driven by government initiatives and favorable economic conditions. Countries like India, China, and South Korea are major hubs for pharmaceutical production. For instance, India, often referred to as the "pharmacy of the world," is expanding its pharmaceutical manufacturing base to meet global demand for generic drugs.

The demand for biologics, vaccines, and specialized pharmaceutical products is growing rapidly in the APAC region. These products often require advanced sealing solutions to maintain product stability and prevent contamination. For instance, the production of COVID-19 vaccines, particularly in China and India, has highlighted the need for sealing machines that can handle complex packaging requirements and ensure product integrity during distribution.

As the pharmaceutical manufacturing sector expands rapidly in this region, the demand for advanced sealing technologies is set to rise, particularly with the increasing production of biopharmaceuticals and vaccines. The combination of technological advancements, favorable economic conditions and strategic government initiatives is positioning the APAC region as the fastest-growing market in the pharmaceutical sealing machines landscape.

Competitive Landscape

The major global players in the pharmaceutical sealing machines market include Marchesini Group S.p.A., Uhlmann Pac-Systeme GmbH & Co. KG, MULTIVAC Group, I.M.A. Industria Macchine Automatiche S.p.A., MG2 s.r.l., PlexPack, Bausch+Strobel SE + Co. KG, Audion, Syntegon Technology GmbH, MGA Technologies and among others.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global pharmaceutical sealing machines market report delivers a detailed analysis with 62 key tables, more than 52 visually impactful figures, and 179 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Machine Type
  • 2.4. Snippet by Technology
  • 2.5. Snippet by End-User
  • 2.6. Snippet by Region

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Growth in Pharmaceutical Manufacturing
      • 3.1.1.2. Rising Technological Advancements
    • 3.1.2. Restraints
      • 3.1.2.1. Growth in Pharmaceutical Manufacturing
    • 3.1.3. Opportunity
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established leaders with largest selling Brand
    • 4.1.3. Market leaders with established Product
  • 4.2. Emerging Startups and Key Innovators
  • 4.3. CXO Perspectives
  • 4.4. Latest Developments and Breakthroughs
  • 4.5. Case Studies/Ongoing Research
  • 4.6. Regulatory and Reimbursement Landscape
    • 4.6.1. North America
    • 4.6.2. Europe
    • 4.6.3. Asia Pacific
    • 4.6.4. Latin America
    • 4.6.5. Middle East & Africa
  • 4.7. Porter's Five Force Analysis
  • 4.8. Supply Chain Analysis
  • 4.9. Patent Analysis
  • 4.10. SWOT Analysis
  • 4.11. Unmet Needs and Gaps
  • 4.12. Recommended Strategies for Market Entry and Expansion
  • 4.13. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.14. Pricing Analysis and Price Dynamics

5. Pharmaceutical Sealing Machines Market, By Machine Type

  • 5.1. Introduction
    • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Machine Type
    • 5.1.2. Market Attractiveness Index, By Machine Type
  • 5.2. Vial Cap Sealing Machines*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 5.3. Induction Sealing Machines
  • 5.4. Tray Sealing Machines

6. Pharmaceutical Sealing Machines Market, By Technology

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 6.1.2. Market Attractiveness Index, By Technology
  • 6.2. Automatic Sealing Machines*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Semi-Automatic Sealing Machines
  • 6.4. Manual Sealing Machines

7. Pharmaceutical Sealing Machines Market, By End-User

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 7.1.2. Market Attractiveness Index, By End-User
  • 7.2. Pharmaceutical Companies*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Contract Packaging Organizations
  • 7.4. Research Laboratories

8. Pharmaceutical Sealing Machines Market, By Regional Market Analysis and Growth Opportunities

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 8.1.2. Market Attractiveness Index, By Region
  • 8.2. North America
    • 8.2.1. Introduction
    • 8.2.2. Key Region-Specific Dynamics
    • 8.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Machine Type
    • 8.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 8.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.2.6.1. U.S.
      • 8.2.6.2. Canada
      • 8.2.6.3. Mexico
  • 8.3. Europe
    • 8.3.1. Introduction
    • 8.3.2. Key Region-Specific Dynamics
    • 8.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Machine Type
    • 8.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 8.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.3.6.1. Germany
      • 8.3.6.2. U.K.
      • 8.3.6.3. France
      • 8.3.6.4. Spain
      • 8.3.6.5. Italy
      • 8.3.6.6. Rest of Europe
  • 8.4. South America
    • 8.4.1. Introduction
    • 8.4.2. Key Region-Specific Dynamics
    • 8.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Machine Type
    • 8.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 8.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.4.6.1. Brazil
      • 8.4.6.2. Argentina
      • 8.4.6.3. Rest of South America
  • 8.5. Asia-Pacific
    • 8.5.1. Introduction
    • 8.5.2. Key Region-Specific Dynamics
    • 8.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Machine Type
    • 8.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 8.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.5.6.1. China
      • 8.5.6.2. India
      • 8.5.6.3. Japan
      • 8.5.6.4. South Korea
      • 8.5.6.5. Rest of Asia-Pacific
  • 8.6. Middle East and Africa
    • 8.6.1. Introduction
    • 8.6.2. Key Region-Specific Dynamics
    • 8.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Machine Type
    • 8.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 8.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

9. Competitive Landscape and Market Positioning

  • 9.1. Competitive Overview and Key Market Players
  • 9.2. Market Share Analysis and Positioning Matrix
  • 9.3. Strategic Partnerships, Mergers & Acquisitions
  • 9.4. Key Developments in Product Portfolios and Innovations
  • 9.5. Company Benchmarking

10. Company Profiles

  • 10.1. Marchesini Group S.p.A.*
    • 10.1.1. Company Overview
    • 10.1.2. Product Portfolio and Description
    • 10.1.3. Financial Overview
    • 10.1.4. Key Developments
    • 10.1.5. SWOT Analysis
  • 10.2. Uhlmann Pac-Systeme GmbH & Co. KG
  • 10.3. MULTIVAC Group
  • 10.4. I.M.A. Industria Macchine Automatiche S.p.A.
  • 10.5. MG2 s.r.l.
  • 10.6. PlexPack
  • 10.7. Bausch+Strobel SE + Co. KG
  • 10.8. Audion
  • 10.9. Syntegon Technology GmbH
  • 10.10. MGA Technologies

LIST NOT EXHAUSTIVE

11. Assumption and Research Methodology

  • 11.1. Data Collection Methods
  • 11.2. Data Triangulation
  • 11.3. Forecasting Techniques
  • 11.4. Data Verification and Validation

12. Appendix

  • 12.1. About Us and Services
  • 12.2. Contact Us